Avantax Advisory Services’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-37,432
Closed -$131K 1175
2021
Q1
$131K Buy
37,432
+16,293
+77% +$90.7K ﹤0.01% 993
2020
Q4
$100K Buy
+21,139
New +$109K ﹤0.01% 910

Other funds holding CEMI

Avantax Advisory Services's CEMI Position: Q2 2021 in Review

Avantax Advisory Services sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 37,432 shares — an estimated $131K sold.

Avantax Advisory Services first reported a position in CEMI in Q4 2020 and held it in 2 quarters. The position peaked at $131K in Q1 2021. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

  • Avantax Advisory Services reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Avantax Advisory Services sold 37,432 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $131K.
  • Avantax Advisory Services first reported a position in Chembio diagnostics, Inc. in Q4 2020 and held it in 2 quarters.
  • Avantax Advisory Services's Chembio diagnostics, Inc. position peaked at $131K in Q1 2021.
  • 60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Avantax Advisory Services's 13F filing for Q2 2021, filed 29 Jul 2021.